“Doubling time of untreated metastases ranged from 34 to 220 days (median, 63 days). Regardless of the presumed size of metastasis at last screening, two thirds of the metastases had a DT (doubling time) between 30 and 80 days.”
-http://www.sciencedirect.com/science/article/pii/S0161642000001822
“We identified monosomy of chromosome 3 in tumors from four patients with an average survival of 5 months (range 1-8 months) from time of diagnosis of metastatic disease. In contrast, tumors with either disomy or partial chromosome 3 alterations showed significantly slower metastatic disease progression with an average survival of 69 months (range 40-123 months, p = 0.003).”
- (behind a paywall) Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Experimental Eye Research. 100 (pp 26-31), 2012. Date of Publication: July 2012.